Catalyst Wire Dossier Catalyst Wire Dossier

Olanzapine Extended-Release (SC) formulations

olanzapine · Teva Branded Pharmaceutical Products R&D LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Olanzapine Extended-Release (SC) formulations, covering 2026-01-26 to 2026-01-26. Get the full timeline:

Most recent: Clinical Trial Update: Open-label Trial Characterizing the PK of 3 SC Olanzapine Extended-release Formulations in Participants With Schizophrenia/Schizoaffective Disorder [Phase 1]

See pricing